Fractyl Health Analyst Price Targets

Wall Street analyst price targets and consensus rating for Fractyl Health (GUTS).

Price Target Range — 9 Quarters

Analyst Consensus — 5 Analysts

5Buy

Consensus RatingBuy# Analysts5Avg. Consensus PT$62Upside to Avg. PT+5729.0%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 20, 2026	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$96→$39
Oct 19, 2026	Morgan Stanley	Michael Ulz	PT Cut	Equal-Weight	$24→$4
Jul 1, 2026	Craig-Hallum	Chase Knickerbocker	Initiate	Buy	$4
Jun 4, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$8
Apr 24, 2026	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$8
Mar 26, 2026	Canaccord Genuity	Whitney Ijem	Maintained	Buy	$8
Jan 30, 2026	Morgan Stanley	Michael Ulz	Downgrade	Overweight→Equal-Weight	$8→$2
Dec 2, 2025	HC Wainwright & Co.	Joseph Pantginis	Maintained	Buy	$8
Nov 21, 2025	Canaccord Genuity	Whitney Ijem	PT Raise	Buy	$6→$8
Sep 26, 2025	HC Wainwright & Co.	Joseph Pantginis	PT Cut	Buy	$9→$8
Sep 15, 2025	HC Wainwright & Co.	Joseph Pantginis	Initiate	Buy	$9
Aug 28, 2025	Ladenburg Thalmann	Jeff Cohen	Initiate	Buy	$4
Aug 14, 2025	Canaccord Genuity	Whitney Ijem	PT Cut	Buy	$12→$6
Apr 15, 2025	Canaccord Genuity	—	Initiate	Buy	$12
Feb 3, 2025	Morgan Stanley	Michael Ulz	PT Cut	Overweight	$18→$10
Feb 28, 2024	Evercore ISI Group	Umer Raffat	Initiate	Outperform	—
Feb 27, 2024	Morgan Stanley	Michael Ulz	Initiate	Overweight	$18

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39

Canaccord Genuity analyst Whitney Ijem maintains Fractyl Health (NASDAQ:GUTS) with a Buy and lowers the price target from $96 to $39.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4

Morgan Stanley analyst Michael Ulz maintains Fractyl Health (NASDAQ:GUTS) with a Equal-Weight and lowers the price target from $24 to $4.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.

Benzinga Newsdesk

PRO
Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

Morgan Stanley analyst Michael Ulz downgrades Fractyl Health (NASDAQ:GUTS) from Overweight to Equal-Weight and lowers the price target from $8 to $2.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

HC Wainwright & Co. analyst Joseph Pantginis reiterates Fractyl Health (NASDAQ:GUTS) with a Buy and maintains $8 price target.

Benzinga Newsdesk

Fractyl Health Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Fractyl Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39

PRO
Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

PRO
Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

People Also Watch

People Also Watch

Fractyl Health Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Fractyl Health Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROCanaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39

PROMorgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4

PROHC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

PROHC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

PROMorgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

PROHC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

People Also Watch

People Also Watch

PRO
Canaccord Genuity Maintains Buy on Fractyl Health, Lowers Price Target to $39

PRO
Morgan Stanley Maintains Equal-Weight on Fractyl Health, Lowers Price Target to $4

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target

PRO
Morgan Stanley Downgrades Fractyl Health to Equal-Weight, Lowers Price Target to $2

PRO
HC Wainwright & Co. Reiterates Buy on Fractyl Health, Maintains $8 Price Target